Corpus ID: 25689156

Pharmacokinetics of acarbose. Part I: Absorption, concentration in plasma, metabolism and excretion after single administration of [14C]acarbose to rats, dogs and man.

@article{Ahr1989PharmacokineticsOA,
  title={Pharmacokinetics of acarbose. Part I: Absorption, concentration in plasma, metabolism and excretion after single administration of [14C]acarbose to rats, dogs and man.},
  author={H. Ahr and M. Boberg and H. P. Krause and W. Maul and F. Mueller and H. Ploschke and H. Weber and C. Wuensche},
  journal={Arzneimittel-Forschung},
  year={1989},
  volume={39 10},
  pages={
          1254-60
        }
}
  • H. Ahr, M. Boberg, +5 authors C. Wuensche
  • Published 1989
  • Chemistry, Medicine
  • Arzneimittel-Forschung
  • The absorption, disposition, metabolism, and excretion of acarbose (O-4,6-dideoxy-4-[[(1S, 4R, 5S, 6S)-4,5,6-trihydroxy-3- (hydroxymethyl)-2- cyclohexen-1-yl]amino]-a-D-glucopyranosyl- (1----4)-O-a-D-glucopyranosyl- (1----4) -D-glucopyranose, Bay g 5421) have been studied following a single administration of the 14C-labelled compound to rats and dogs via different routes (intravenous, oral, intraduodenal) in the dose range of 2-200 mg.kg-1 as well as to man in a single oral dose of 200 mg… CONTINUE READING
    51 Citations
    Revised Etiologic Classification of Diabetes
    • 1
    Pharmacokinetic-Pharmacodynamic Relationships of Acarbose
    • 64
    • PDF
    The effect of acarbose on the pharmacokinetics of rosiglitazone
    • 21
    Alpha-Amylase Inhibitor, CS-1036 Binds to Serum Amylase in a Concentration-Dependent and Saturable Manner
    • 2
    • PDF
    Biotechnology and molecular biology of the α-glucosidase inhibitor acarbose
    • 126